Molecular modeling of nearly full-length ErbB2 receptor

Biophysical Journal

Volumn 88, Issue 2, 2005, Pages 1354-1363

  Bagossi, Péter ^a   Horváth, Gábor ^a   Vereb, György ^a   Szöllösi, János ^a   Tözsér, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN TYROSINE KINASE;

ARTICLE; AUTOPHOSPHORYLATION; DIMERIZATION; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SIGNAL TRANSDUCTION; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; COMPUTER SIMULATION; LIPID BILAYER; METHODOLOGY; NEOPLASM; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; COMPUTER SIMULATION; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LIPID BILAYERS; MODELS, CHEMICAL; MODELS, MOLECULAR; NEOPLASMS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ERBB-2; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 19444366195     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.046003     Document Type: Article

References (70)

1. Bastiaens, P. I., and T. M. Jovin. 1996. Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C beta I. Proc. Natl. Acad. Sci. USA. 93:8407-8412.
2. Bell, C. A., J. A. Tynan, K. C. Hart, A. N. Meyer, S. C. Robertson. and D. J. Donoghue. 2000. Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase. Mol. Biol. Cell. 11:3589-3599.
3. Berman, H. M., J. Westbrook, Z. Feng, G. Gilliland, T. N. Bhat, H. Weissig, I. N. Shindyalov, and P. E. Bourne. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
4. Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature. 411:355-365.
5. Burgess, A. W., H. S. Cho, C. Eigenbrot, K. M. Ferguson, T. P. Garrett, D. J. Leahy, M. A. Lemmon, M. X. Sliwkowski, C. W. Ward, and S. Yokoyama. 2003. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell. 12:541-552.
6. Burke, C. L., and D. F. Stern. 1998. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol. Cell. Biol. 18:5371-5379.
7. Carter, P., B. M. Fendly, G. D. Lewis, and M. X. Sliwkowski. 1999. Development of Herceptin. Breast Disease. 11:103-111.
8. Carter, P., L. Presta, C. M. Gorman, J. B. Ridgway, D. Henner, W. L. Wong, A. M. Rowland, C. Kotts, M. E. Carver, and H. M. Shepard. 1992. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA. 89:4285-4289.
9. Cho, H. S., and D. J. Leahy. 2002. Structure of the extracellular region of HER3 reveals an interdomain tether. Science. 297:1330-1333.
10. Cho, H. S., K. Mason, K. X. Ramyar, A. M. Stanley, S. B. Gabelll, D. W. Denney, Jr., and D. J. Leahy. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature. 421:756-760.
11. Chu, C. T., K. D. Everiss, C. J. Wikstrand, S. K. Batra, H. J. Kung, and D. D. Bigner. 1997. Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochem. J. 324:855-861.
12. Cirri, A., K. B. Skaria, and Y. Yarden. 2003. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 284:54-65.
13. Cuff, J. A., and G. J. Barton. 1999. Evaluation and improvement of multiple sequence methods for protein secondary structure prediction. Proteins. 34:508-519.
14. de Bono, J. S., and E. K. Rowinsky. 2002. The ErbB receptor family: a therapeutic target for cancer. Trends Mol. Med. 8(4 Suppl):S19-S26.
15. Deisenhofer, J., O. Epp. I. Sinning, and H. Michel. 1995. Crystallographic refinement at 2.3 A resolution and refined model of the photosynthetic reaction centre from Rhodopseitdomonas viridis. J. Mol. Biol. 246:429-457.
16. Ferguson, K. M., M. B. Berger, J. M. Mendrola, H. S. Cho, D. J. Leahy, and M. A. Lemmon. 2003. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell. 11:507-517.
17. Ferguson, K. M., P. J. Darling, M. J. Mohan, T. L. Macatee, and M. A. Lemmon. 2000. Extracellular domains drive homo- but not heterodimerization of ErbB receptors. EMBO J. 19:4632-4643.
18. Fleishman, S. J., J. Schlessinger, and N. Ben-Tal. 2002. A putative molecular-activation switch in the transmembrane domain of ErbB2. Proc. Natl. Acad. Sci. USA. 99:15937-15940.
19. Förster. T. 1948. Intermolecular energy transfer and fluorescence. Annal. Physik. 2:55-75.
20. Förster. T. 1949. Experimental and theoretical investigation of intermolecular transfer of electronic excitiation energy. Z. Naturforsch. 4a:321-327.
21. Gadella, T. W., Jr., and T. M. Jovin. 1995. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 129:1543-1558.
22. Gamier, J., J. F. Gibrat, and B. Robson. 1996. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol. 266:540-553.
23. Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120:97-120.
24. Garrett, T. P., N. M. McKern, M. Lou, T. C. Elleman, T. E. Adams, G. O. Lovrecz, M. Kofler, R. N. Jorissen, E. C. Nice, A. W. Burgess, and C. W. Ward. 2003. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Mol. Cell. 11:495-505.
25. Garrett, T. P., N. M. McKern, M. Lou, T. C. Elleman, T. E. Adams, G. O. Lovrecz, H. J. Zhu, F. Walker, M. J. Frenkel, P. A. Hoyne, and R. N. Jorissen, E. C. Nice, A. W. Burgess, and C. W. Ward. 2002. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell. 110:763-773.
26. Gáspár, R., Jr., P. Bagossi, L. Bene, J. Matkó, J. Szöllösi, S. Tözsér, L. Fésüs, T. A. Waldmann, and S. Damjanovich. 2001. Clustering of class I HLA oligomers with CD8 and TCR: three-dimensional models based on fluorescence resonance energy transfer and crystallographic data. J. Immunol. 166:5078-5086.
27. Geourjon, C., and G. Deleage. 1995. SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput. Appl. Biosci. 11:681-684.
28. Gerber, D., N. Sal-Man, and Y. Shai. 2004. Two motifs within a transmembrane domain-one for homodimerization and the other for heterodimerization. J. Biol. Chem. 279:21177-21182.
29. Goetz, M., C. Carlotti, F. Bontems, and E. J. Dufourc. 2001. Evidence for an α-helix → π-bulge helicity modulation for the Neu/ErbB-2 membrane-spanning segment. A 1H-NMR and circular dichroism study. Biochemistry. 40:6534-6540.
30. Guermeur, Y., C. Geourjon, P. Gallinari, and G. Deleage. 1999. Improved performance in protein secondary structure prediction by inhomogeneous score combination. Bioinformatics. 15:413-421.
31. Jackson, J. G., P. St Clair, M. X. Sliwkowski, and M. G. Brattain. 2004. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Cancer Res. 64:2601-2609.
32. Kim, S., A. K. Chamberlain, and J. U. Bowie. 2003. A simple method for modeling transmembrane helix oligomers. J. Mol. Biol. 329:831-840.
33. Koeppen, H. K., B. D. Wright, A. D. Hurt, P. Quirke, A. M. McNicol, N. O. Dybdal, M. X. Sliwkowski, and K. J. Hillan. 2001. Overexpression of HER2/Neu in solid tumours: an immunohistochemical survey. Histopathology. 38:96-104.
34. Kumagai, T., M. Katsumata, A. Hasegawa, K. Furuuchi, T. Funakoshi, I. Kawase, and M. I. Greene. 2003. Role of extracellular subdomains of p185c-Neu and the epidermal growth factor receptor in ligand-independent association and transactivation. Proc. Natl. Acad. Sci. USA. 100:9220-9225.
35. Kute, T., C. M. Lack, M. Willingham, B. Bishwokama, H. Williams, K. Barren, T. Mitchell, and J. P. Vaughn. 2004. Development of Herceptin resistance in breast cancer cells. Cytometry. 57A:86-93.
36. MacKenzie, K. R., J. H. Prestegard, and D. M. Engelman. 1997. A transmembrane helix dimer: structure and implications. Science. 276:131-133.
37. Marmor, M. D., K. B. Skaria, and Y. Yarden. 2004. Signal transduction and oncogenesis by ErbB/HER receptors. Int. J. Radiat. Oncol. Biol. Phys. 58:903-913.
38. Maxfield, F. R., and H. A. Scheraga. 1976. Status of empirical methods for the prediction of protein backbone topography. Biochemistry. 15:5138-5153.
39. Mendrola, J. M., M. B. Berger, M. C. King, and M. A. Lemmon. 2002. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J. Biol. Chem. 277:4704-4712.
40. Moriki, T., H. Maruyama, and I. N. Maruyama. 2001. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311:1011-1026.
41. Nagy, P., L. Bene, M. Balázs, W. C. Hyun, S. J. Lockett, N. Y. Chiang, F. Waldman, B. G. Feuerstein, S. Damjanovich, and J. Szöllösi. 1998. EGF-induced redistribution of ErbB2 on breast tumor cells: flow and image cytometric energy transfer measurements. Cytometry. 32:120-131.
42. Nagy, P., G. Vereb, Z. Sebestyén, G. Horváth, S. J. Lockett, S. Damjanovich, J. W. Park, T. M. Jovin, and J. Szöllösi. 2002. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J. Cell Sci. 115:4251-4262.
43. Ogiso, H., R. Ishitani, O. Nureki, S. Fukai, M. Yamanaka, J. H. Kim, K. Saito, A. Sakamoto, M. Inoue, M. Shirouzu, and S. Yokoyama. 2002. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell. 110:775-787.
44. Paik, S., and E. T. Liu. 1999. HER2 as a predictor of therapeutic response in breast cancer. Breast Disease. 11:91-102.
45. Pebay-Peyroula, E., G. Rummel, J. P. Rosenbusch, and E. M. Landau. 1997. X-ray structure of bacteriorhodopsin at 2.5 Angstroms from microcrystals grown in lipidic cubic phases. Science. 277:1676-1681.
46. Penuel, E., R. W. Akita, and M. X. Sliwkowski. 2002. Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association. J. Biol. Chem. 277:28468-28473.
47. Press, M. F., M. C. Pike, G. Hung, J. Y. Zhou, Y. Ma, J. George, J. Dietz-Band, W. James, D. J. Slamon, and J. G. Batsakis. 1994. Amplification and overexpression of HER-2/Neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res. 54:5675-5682.
48. Qian, N., and T. J. Sejnowski. 1988. Predicting the secondary structure of globular proteins using neural network models. J. Mol. Biol. 202:865-884.
49. Ranson, M., and M. X. Sliwkowski. 2002. Perspectives on anti-HER monoclonal antibodies. Oncology. 63(Suppl 1):17-24.
50. Ross, J. S., and J. A. Fletcher. 1998. The HER-2/Neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Oncologist. 3:237-252.
51. Sali, A., and T. L. Blundell. 1993. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234:779-815.
52. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell. 103:211-225.
53. Sebestyen, Z., P. Nagy, G. Horváth, G. Vamosi, R. Debets, J. W. Gratama, D. R. Alexander, and J. Szöllösi. 2002. Long wavelength fluorophores and cell-by-cell correction for autofluorescence significantly improves the accuracy of flow cytometric energy transfer measurements on a dual-laser benchtop flow cytometer. Cytometry. 48:124-135.
54. Sharpe, S., K. R. Barber, and C. W. Grant. 2002. Evidence of a tendency to self-association of the transmembrane domain of ErbB-2 in fluid phospholipid bilayers. Biochemistry. 41:2341-2352.
55. Siegel, P. M., and W. J. Muller. 1996. Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc. Natl. Acad. Sci. USA. 93:8878-8883.
56. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/Neu oncogene. Science. 235:177-182.
57. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/Neu proto-oncogene in human breast and ovarian cancer. Science. 244:707-712.
58. Sorokin, A., M. A. Lemmon, A. Ullrich, and J. Schlessinger. 1994. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269:9752-9759.
59. Stamos, J., M. X. Sliwkowski, and C. Eigenbrot. 2002. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J. Biol. Chem. 277:46265-46272.
60. Szentesi, G., G. Horváth, I. Bori, G. Vámosi, J. Szöllösi, R. Gáspár, S. Damjanovich, A. Jenei, and L. Mátyus. 2004. Computer program for determining fluorescence resonance energy transfer efficiency from flow cytometric data on a cell-by-cell basis. Comput. Methods Programs Biomed. 75:201-211.
61. Szöllösi, J., V. Horejsi, L. Bene, P. Angelisova, and S. Damjanovich. 1996. Supramolecular complexes of MHC class I, MHC class IL CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:2939-2946.
62. Szöllösi, J., P. Nagy, Z. Sebestyén, S. Damjanovich, J. W. Park, and L. Mátyus. 2002. Applications of fluorescence resonance energy transfer for mapping biological membranes. J. Biotechnol. 82:251-266.
63. Szöllösi, J., L. Trón, S. Damjanovich, S. H. Helliwell, D. Arndt-Jovin, and T. M. Jovin. 1984. Fluorescence energy transfer measurements on cell surfaces: a critical comparison of steady-state fluorimetric and flow cytometric methods. Cytometry. 5:210-216.
64. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
65. Trón, L., J. Szöllösi, S. Damjanovich, S. H. Helliwell, D. J. Arndt-Jovin, and T. M. Jovin. 1984. Flow cytometric measurement of fluorescence resonance energy transfer on cell surfaces. Quantitative evaluation of the transfer efficiency on a cell-by-cell basis. Biophys. J. 45:939-946.
66. Valenzuela, C. F., P. Weign, J. Yguerabide, and D. A. Johnson. 1994. Transverse distance between the membrane and the agonist binding sites on the Torpedo acetylcholine receptor: a fluorescence study. Biophys. J. 66:674-682.
67. Vereb, G., P. Nagy, J. W. Park, and J. Szöllösi. 2002. Signaling revealed by mapping molecular interactions: implications for ErbB-targeted cancer immunotherapies. Clin. Appl. Immunol. Rev. 2:169-186.
68. Vereb, G., J. Szöllösi, J. Matkó, P. Nagy, T. Farkas, L. Vigh, L. Mátyus, T. A. Waldmann, and S. Damjanovich. 2003. Dynamic, yet structured: the cell membrane three decades after the Singer-Nicolson model. Proc. Natl. Acad. Sci. USA. 100:8053-8058.
69. Yarden, Y. 2001. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur. J. Cancer. 37:S3-S8.
70. Yguerabide, J. 1994. Theory for establishing proximity relations in biological membranes by excitation energy transfer measurements. Biophys. J. 66:683-693.